Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder, Overactive | 11 | 2025 | 95 | 3.660 |
Why?
|
| Suburethral Slings | 5 | 2020 | 77 | 2.440 |
Why?
|
| Urinary Incontinence | 4 | 2023 | 217 | 1.960 |
Why?
|
| Urology | 6 | 2024 | 133 | 1.930 |
Why?
|
| Urologic Surgical Procedures | 7 | 2024 | 152 | 1.890 |
Why?
|
| Lower Urinary Tract Symptoms | 4 | 2022 | 82 | 1.840 |
Why?
|
| Urinary Incontinence, Stress | 5 | 2017 | 198 | 1.450 |
Why?
|
| Prostatic Hyperplasia | 4 | 2016 | 95 | 1.430 |
Why?
|
| Urinary Bladder Neck Obstruction | 3 | 2022 | 26 | 1.410 |
Why?
|
| Laser Therapy | 4 | 2016 | 151 | 1.390 |
Why?
|
| Urodynamics | 7 | 2025 | 127 | 1.380 |
Why?
|
| Social Media | 2 | 2023 | 111 | 1.230 |
Why?
|
| Postoperative Complications | 8 | 2024 | 2562 | 1.140 |
Why?
|
| Diabetes Complications | 2 | 2020 | 170 | 1.130 |
Why?
|
| Prostatectomy | 4 | 2016 | 478 | 1.080 |
Why?
|
| Prostatism | 3 | 2010 | 5 | 0.970 |
Why?
|
| Thulium | 2 | 2016 | 2 | 0.930 |
Why?
|
| Lasers, Solid-State | 2 | 2016 | 8 | 0.920 |
Why?
|
| Pelvic Organ Prolapse | 4 | 2023 | 170 | 0.890 |
Why?
|
| Uterine Prolapse | 3 | 2023 | 82 | 0.860 |
Why?
|
| Urinary Tract Infections | 6 | 2023 | 85 | 0.840 |
Why?
|
| Urinary Bladder | 4 | 2022 | 260 | 0.820 |
Why?
|
| Transurethral Resection of Prostate | 3 | 2014 | 10 | 0.820 |
Why?
|
| Spinal Cord Injuries | 2 | 2022 | 109 | 0.780 |
Why?
|
| Surgery, Plastic | 1 | 2023 | 38 | 0.780 |
Why?
|
| Cystitis, Interstitial | 1 | 2023 | 55 | 0.760 |
Why?
|
| Nocturia | 1 | 2022 | 23 | 0.750 |
Why?
|
| Electric Stimulation Therapy | 1 | 2022 | 53 | 0.710 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2018 | 29 | 0.690 |
Why?
|
| Muscarinic Antagonists | 3 | 2010 | 59 | 0.680 |
Why?
|
| Vagina | 3 | 2022 | 177 | 0.650 |
Why?
|
| Phenylpropanolamine | 2 | 2010 | 15 | 0.620 |
Why?
|
| Cresols | 2 | 2010 | 17 | 0.620 |
Why?
|
| Comprehension | 1 | 2020 | 82 | 0.620 |
Why?
|
| Hysterectomy | 2 | 2022 | 167 | 0.610 |
Why?
|
| Humans | 57 | 2025 | 93515 | 0.610 |
Why?
|
| Benzhydryl Compounds | 2 | 2010 | 46 | 0.610 |
Why?
|
| Female | 36 | 2025 | 48702 | 0.590 |
Why?
|
| Video Recording | 1 | 2020 | 212 | 0.590 |
Why?
|
| Smoking | 5 | 2007 | 648 | 0.580 |
Why?
|
| Botulinum Toxins, Type A | 3 | 2025 | 53 | 0.580 |
Why?
|
| Middle Aged | 29 | 2025 | 27573 | 0.580 |
Why?
|
| Spinal Dysraphism | 1 | 2018 | 28 | 0.560 |
Why?
|
| Urinary Bladder Diseases | 1 | 2017 | 42 | 0.520 |
Why?
|
| Surgical Mesh | 2 | 2022 | 125 | 0.520 |
Why?
|
| Cystocele | 1 | 2017 | 7 | 0.520 |
Why?
|
| Aged | 21 | 2025 | 20434 | 0.520 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 373 | 0.510 |
Why?
|
| Retrospective Studies | 13 | 2025 | 10164 | 0.510 |
Why?
|
| Vesicovaginal Fistula | 1 | 2016 | 12 | 0.500 |
Why?
|
| Cystectomy | 1 | 2017 | 113 | 0.490 |
Why?
|
| Internship and Residency | 2 | 2023 | 1090 | 0.490 |
Why?
|
| Gynecology | 1 | 2017 | 130 | 0.460 |
Why?
|
| Alcoholism | 5 | 2005 | 188 | 0.440 |
Why?
|
| Adult | 25 | 2025 | 27918 | 0.420 |
Why?
|
| Male | 31 | 2025 | 44557 | 0.410 |
Why?
|
| Azasteroids | 2 | 2012 | 5 | 0.410 |
Why?
|
| Databases, Factual | 4 | 2020 | 1006 | 0.400 |
Why?
|
| Urinary Retention | 2 | 2025 | 44 | 0.400 |
Why?
|
| Ethanol | 6 | 2006 | 273 | 0.390 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 624 | 0.360 |
Why?
|
| Treatment Outcome | 8 | 2022 | 9099 | 0.350 |
Why?
|
| Naltrexone | 3 | 2004 | 139 | 0.350 |
Why?
|
| Urination | 3 | 2016 | 39 | 0.340 |
Why?
|
| Prostate | 3 | 2012 | 416 | 0.330 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 2802 | 0.330 |
Why?
|
| United States | 5 | 2024 | 7622 | 0.320 |
Why?
|
| Urethral Diseases | 1 | 2010 | 14 | 0.320 |
Why?
|
| Alcohol Drinking | 5 | 2006 | 283 | 0.320 |
Why?
|
| Diverticulum | 1 | 2010 | 44 | 0.310 |
Why?
|
| Diagnostic Errors | 1 | 2010 | 157 | 0.290 |
Why?
|
| Smoking Cessation | 3 | 2007 | 269 | 0.290 |
Why?
|
| Anticoagulants | 1 | 2011 | 457 | 0.270 |
Why?
|
| Quality of Life | 4 | 2022 | 1780 | 0.270 |
Why?
|
| Operative Time | 2 | 2018 | 167 | 0.260 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1931 | 0.250 |
Why?
|
| Research Subjects | 1 | 2017 | 73 | 0.250 |
Why?
|
| Substance Abuse Treatment Centers | 2 | 2004 | 25 | 0.230 |
Why?
|
| Hydrocortisone | 4 | 2005 | 296 | 0.230 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2017 | 163 | 0.230 |
Why?
|
| Neuromuscular Agents | 1 | 2025 | 27 | 0.220 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 137 | 0.220 |
Why?
|
| Comorbidity | 2 | 2020 | 1007 | 0.220 |
Why?
|
| Organ Size | 3 | 2016 | 362 | 0.210 |
Why?
|
| Urologists | 1 | 2024 | 34 | 0.210 |
Why?
|
| Education, Medical, Graduate | 2 | 2023 | 425 | 0.210 |
Why?
|
| Patient Dropouts | 1 | 2004 | 31 | 0.210 |
Why?
|
| Self-Help Groups | 1 | 2023 | 14 | 0.200 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1161 | 0.200 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 7061 | 0.200 |
Why?
|
| Patient Selection | 1 | 2017 | 690 | 0.200 |
Why?
|
| Pelvic Floor Disorders | 1 | 2023 | 57 | 0.190 |
Why?
|
| Stress, Psychological | 3 | 2005 | 342 | 0.190 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 3830 | 0.190 |
Why?
|
| Risk Factors | 5 | 2025 | 5899 | 0.190 |
Why?
|
| Tibial Nerve | 1 | 2022 | 13 | 0.180 |
Why?
|
| Sacrococcygeal Region | 1 | 2022 | 13 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2017 | 438 | 0.180 |
Why?
|
| Placenta Accreta | 1 | 2022 | 10 | 0.180 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 28 | 0.180 |
Why?
|
| Child | 2 | 2023 | 7355 | 0.180 |
Why?
|
| Prostate-Specific Antigen | 2 | 2014 | 337 | 0.170 |
Why?
|
| Urethral Stricture | 1 | 2020 | 15 | 0.160 |
Why?
|
| Prospective Studies | 6 | 2022 | 4560 | 0.160 |
Why?
|
| Crohn Disease | 1 | 2007 | 808 | 0.160 |
Why?
|
| Tolterodine Tartrate | 2 | 2010 | 15 | 0.160 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 800 | 0.160 |
Why?
|
| Urethra | 1 | 2020 | 113 | 0.150 |
Why?
|
| Surgeons | 1 | 2024 | 292 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2004 | 441 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 985 | 0.150 |
Why?
|
| Surgical Flaps | 2 | 2020 | 252 | 0.140 |
Why?
|
| Education | 1 | 2018 | 59 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3476 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2018 | 30 | 0.140 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 40 | 0.140 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 115 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2020 | 917 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2018 | 109 | 0.130 |
Why?
|
| Incontinence Pads | 1 | 2016 | 4 | 0.120 |
Why?
|
| Temperance | 2 | 2003 | 6 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2016 | 175 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 121 | 0.110 |
Why?
|
| Central Nervous System Depressants | 1 | 2005 | 45 | 0.110 |
Why?
|
| Cues | 1 | 2006 | 186 | 0.110 |
Why?
|
| Volatilization | 1 | 2014 | 6 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 135 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2016 | 257 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2018 | 485 | 0.100 |
Why?
|
| Dutasteride | 2 | 2012 | 5 | 0.100 |
Why?
|
| Pursuit, Smooth | 1 | 2004 | 31 | 0.100 |
Why?
|
| Safety | 1 | 2014 | 132 | 0.100 |
Why?
|
| Saccades | 1 | 2004 | 75 | 0.100 |
Why?
|
| Affect | 2 | 2003 | 396 | 0.100 |
Why?
|
| Length of Stay | 1 | 2017 | 828 | 0.100 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2003 | 53 | 0.100 |
Why?
|
| Incidence | 1 | 2017 | 1701 | 0.100 |
Why?
|
| Life Change Events | 1 | 2003 | 46 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2018 | 822 | 0.090 |
Why?
|
| Finasteride | 1 | 2012 | 8 | 0.090 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2012 | 12 | 0.090 |
Why?
|
| Pituitary-Adrenal System | 1 | 2002 | 64 | 0.090 |
Why?
|
| Obesity, Abdominal | 1 | 2012 | 8 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2012 | 24 | 0.090 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2002 | 80 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2018 | 3054 | 0.090 |
Why?
|
| Personality | 1 | 2003 | 140 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2003 | 246 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2004 | 884 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 497 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2002 | 236 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 122 | 0.080 |
Why?
|
| Narcotic Antagonists | 1 | 2002 | 170 | 0.080 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 2010 | 2 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2003 | 333 | 0.080 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2010 | 41 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2010 | 30 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2017 | 2441 | 0.080 |
Why?
|
| Delayed-Action Preparations | 1 | 2010 | 116 | 0.080 |
Why?
|
| Double-Blind Method | 3 | 2005 | 1729 | 0.080 |
Why?
|
| Motivation | 2 | 2017 | 310 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2023 | 443 | 0.080 |
Why?
|
| Young Adult | 2 | 2018 | 6930 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1229 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 759 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 829 | 0.070 |
Why?
|
| Biomarkers | 1 | 2014 | 1910 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2006 | 1914 | 0.070 |
Why?
|
| Hypertension | 1 | 2003 | 757 | 0.070 |
Why?
|
| Tobacco Products | 1 | 2017 | 77 | 0.060 |
Why?
|
| Age of Onset | 1 | 2007 | 342 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 836 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 3147 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 1103 | 0.050 |
Why?
|
| Arousal | 2 | 2005 | 171 | 0.050 |
Why?
|
| Colpotomy | 1 | 2023 | 4 | 0.050 |
Why?
|
| Reference Values | 2 | 2016 | 608 | 0.050 |
Why?
|
| Adolescent | 3 | 2018 | 9606 | 0.050 |
Why?
|
| Forecasting | 1 | 2004 | 293 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2004 | 356 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1953 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2022 | 41 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2022 | 88 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2022 | 131 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 1775 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2012 | 579 | 0.040 |
Why?
|
| Logistic Models | 1 | 2004 | 1243 | 0.040 |
Why?
|
| Dilatation | 1 | 2020 | 47 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 621 | 0.040 |
Why?
|
| Smartphone | 1 | 2020 | 52 | 0.040 |
Why?
|
| Chicago | 1 | 2004 | 1464 | 0.040 |
Why?
|
| Registries | 1 | 2023 | 990 | 0.030 |
Why?
|
| Inappropriate Prescribing | 1 | 2018 | 19 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 2465 | 0.030 |
Why?
|
| Urination Disorders | 1 | 2018 | 55 | 0.030 |
Why?
|
| Internet | 1 | 2020 | 337 | 0.030 |
Why?
|
| Endoscopy | 1 | 2020 | 366 | 0.030 |
Why?
|
| Psychopharmacology | 1 | 2006 | 26 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 13 | 0.030 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2016 | 14 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2022 | 2479 | 0.030 |
Why?
|
| Behavior | 1 | 2006 | 85 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2006 | 164 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 413 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 210 | 0.030 |
Why?
|
| Social Environment | 1 | 2005 | 194 | 0.030 |
Why?
|
| Self Report | 1 | 2016 | 328 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2003 | 43 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 2003 | 34 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 291 | 0.020 |
Why?
|
| Hand Strength | 1 | 2003 | 57 | 0.020 |
Why?
|
| Patient Admission | 1 | 2003 | 119 | 0.020 |
Why?
|
| Speech | 1 | 2003 | 90 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2003 | 99 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2004 | 159 | 0.020 |
Why?
|
| Biotransformation | 1 | 2002 | 46 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2002 | 124 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2012 | 74 | 0.020 |
Why?
|
| Psychometrics | 1 | 2003 | 337 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2002 | 657 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2002 | 543 | 0.020 |
Why?
|
| Sex Factors | 1 | 2003 | 1105 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2715 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1175 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1713 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5410 | 0.020 |
Why?
|